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requirements. The aim of this study was to assess the dosimetric 
performance in clinical conditions of Acuros® XB in relation to AAA. 
Materials and Methods: The clinical dosimetric planning of 60 
patients who underwent treatment for RT, with Rapidarc™ technique 
and calculated with AAA where included in the study. The dosimetric 
plans werere calculated with the Acuros® XB, being compared and 
evaluated on dose-volume histograms (DVH) and radiobiological 
parameters. These 60 patients were divided into 3 groups of 20 
patients each (head and neck, thorax and pelvis). For both plans the 
relative dose values at 5 points of the cumulative DHV for PTV were 
collected: minimum dose (Dmin), near-minimum dose (D98%), medium 
dose (Dmed), near-maximal dose (D2%) and maximal dose (Dmax).  
Results: By comparing the data obtained in this study it was found 
that concerning the relative dose either in overall terms, or in terms 
of compartmental analysis of multiple groups of patients, the AAA 
overestimates the prediction of the dose for all evaluated DVH points 
except for Dmax. The comparison of the results of the averages 
calculated in the dosimetric plans for AAA and for the Acuros® XB 
suggest several scenarios: a reduction of the prescribed dose (Dmed) 
in 1.3%, a decrease also in the near-minimum dose (D98%), a decrease 
of 2.8% in Dmin and an increase in Dmax of 0.8%, which implies a 
decrease in the dose homogeneity inthe plan, and consequently the 
EUD is lower in all plans. 
Conclusions: With the growing interest in RT techniques of volumetric 
modulated arc therapy (VMAT) for various clinical applications, 
Acuros®XB can provide both accuracy and speed of calculation in 
treatment planning. 
 
PO-0816   
What is the best dosimetric technique to deal with respiratory 
motion for lung cancer ? 
A. Crespeau1, S. Krhili2, A. Paumier2, M. Edouard1, C. Di Bartolo1, C. 
Legrand1, J. Mesgouez1, M. Georgin-Mege2, D. Rousseau2, D. Autret1 
1Integrated Center for Oncology, Medical Physics, Angers, France  
2Integrated Center for Oncology, Radiotherapy, Angers, France  
 
Purpose/Objective: To evaluate the dosimetric differences in term of 
target delineation, lung volume and dose delivered to the lungs 
between four respiratory movement management (RMM) techniques 
possibly used in lung tumours irradiation. 
Materials and Methods: Seven patients with one or more primary or 
secondary lung lesions less than 5 cm (11 tumours in total) had four 
CT: free-breathing CT (FB), two deep-inspiration breath-hold (DI-BH) 
CT using a spirometer, and a 4DCT based on the acquisition of ten 
respiratory phases. From these four acquisitions, five treatments plans 
were performed: FB (reference method), DI-BH, and three from the 
4DCT: two breathing synchronized treatments (inspiration (insp) and 
expiration (exp), both based on three phases) and one treatment 
taking into account all the tumours motions (based on ten phases, 
definition of the internal target volume (ITV)). Planning target volume 
(PTV) size and lungs size and dose delivered for the lungs were 
compared. 
Results: Mean PTV for the FB modality was 83 ± 28 cm3, which was 
significantly greater than any of the other techniques (p<0.0001) 
(figure (A)). Compared to the FB PTV, PTV defined with the ITV was 
reduced by one quarter (63 ± 31 cm3). PTV with the DI-BH, breathing 
synchronized inspiration and breathing synchronized expiration 
techniques were reduced by one third (50 to 54, ± 24 to 26 cm3). DI 
led to significantly increase the healthy lung volume compared to 
other methods (mean volume of 5500 ± 1500 cm3 versus 3540 to 3920 
cm3, respectively, p<0.0001) (figure (B)). The volume of healthy lungs 
receiving at least 5 and 20 Gy (V5 and V20) were significantly higher 
with the FB method than any of the other methods (p<0.0001) (figure 
(C) and figure (D)). The DI-BH modality led to the lowest lung V5 and 
V20. 
 
 
Conclusions: First of all, the contouring strategy was different with 
the 4DCT and DI-BH techniques compared to the FB technique. In the 
two first cases, automatic margins were only used to create the PTV 
and only concerned the patient setup accuracy but not the tumour 
displacement, although with the FB technique non personalized and 
automatic margins were applied to create ITV and PTV. Secondly, DI-
BH technique provides the most significant dosimetric advantages: 
small PTV and large lung volume. However, patients must be able to 
hold 20 seconds of apnea, which moreover prevent to perfom CBCT 
images to setup the patient (duration about 45s). Respiratory gating 
(insp and exp) also reduces the PTV, but its application often requires 
the implantation of fiducial which limits its use and the treatment 
time is also important. Finally, an ITV technique allows for a 
personalized and reduced PTV compared to FB technique, and allows 
using CBCT to setup the patient without the implantation of fiducial. 
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Purpose/Objective: The 3D-CRT planning is usually done with trial 
method which is quite time consuming. In this work we tested the 
usage of dose gradient based algorithm for selection of beam weights 
in 3D-CRT plans. Our algorithm is easy to implement for three fields 
technique with wedges defined by planner.  
Materials and Methods: We assume that most homogenous dose 
distribution in target volume, for given set of beam angles and beam 
modifiers, is achieved when the dose gradient at ICRU Reference Point 
(chosen as isocenter point) is equal zero. Therefore calculation of 
beam weights is done in 2D by solving set of equations:  
∑ wi · Di (ICRU) = Dp (ICRU) ;  
∑ wi · grad Di (ICRU) = 0 
 (Di is dose from ith beam normalized to isocenter, Dp is prescribed 
dose, wi –weight of ith beam defined at the ICRU Reference Point). 
First equation guarantees that prescribed dose in isocenter should be 
equal Dp. Second equation sets dose gradient (here in 2D plane) to 
zero. Method was tested for 120 patients, treated in our clinic in 
2011-2012, with different cancer locations (prostate, lung, esophagus, 
rectum, gynecology, stomach). For each patient three fields 
conformal plan (6MV and 15 MV x-ray) with the same geometry as 
proposed by experienced planners were prepared. Beam weights were 
calculated with formulas given above. We compared dose distributions 
achieved with the proposed method and those prepared by 
experienced planners. All other modifications (wedges, MLC, jaws) 
were the same. Both plans were created with the Eclipse Treatment 
Planning System. The homogeneity of dose distributions of 
mathematically optimized and prepared by planners plans were 
compared. The homogeneity was expressed in terms of standard 
deviation and near minimum and maximum doses in the Planning 
Target Volume. All mathematical calculations were performed with 
the help of free Python language. 
Results: Mean difference of standard deviation obtained by the 
proposed algorithm and by planners (with trial-and-error forward 
planning process) was 0.1% (see histogram plot for details): 0.1% for 
prostate cancer, 0.3% for lung cancer, -0.1% for esophagus cancer, 
0.1% for rectum cancer, -0.1% for gynecology cancer, -0.1% for 
stomach cancer. Mean D98% difference was: -0.2% for prostate cancer, 
-0.4% for lung cancer, 0.2% for esophagus cancer, -0.1%for rectum 
cancer, 0.1% for gynecology cancer, 0.2% for stomach cancer. Mean 
D2% difference was: 0.3% for prostate cancer, 0.9% for lung cancer, -
0.1% for esophagus cancer, 0.3% for rectum cancer, 0.3% for 
gynecology cancer, 0.2% for stomach cancer. 
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Conclusions: Proposed algorithm gives dose distribution comparable 
with those achieved by planners and therefore can serve as a support 
in creating 3D-CRT plans. It is also simple in use and can speed up the 
treatment planning process. 
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Purpose/Objective: The UMC Utrecht design of a 1.5T MR scanner 
integrated with a 6MV linear accelerator – or MRL – will have the 
ability of providing fast image-guidance with a high soft-tissue 
contrast, directly during irradiation (RT) with the patient on the MRL. 
MRI-guided treatment opens possibilities for developing new RT 
techniques. In addition, it is necessary to study the effects of the 
magnetic field itself on the dose distribution. Due to the electron 
return effect, the skin dose can be increased, depending on the 
magnetic field strength and the beam/skin inclination angle. Since 
generally large volumes of skin are included in the treatment fields in 
breast cancer patients, the objective of this treatment planning study 
is to investigate the effects on the skin dose in presence of a magnetic 
field, for whole-breast irradiation (WBI) and accelerated partial-
breast irradiation (APBI). 
Materials and Methods: In 11 patients with early-stage breast cancer, 
target volumes and organs at risk (OARs) were delineated on CT scans 
registered with MRI after breast-conserving surgery. Two intensity-
modulated radiotherapy (IMRT) techniques were considered: 
tangential WBI and seven-field APBI. Beam geometries with 
individually optimized beam angles were used for all patients. For 
WBI, dose prescription was 42.56Gy (16x2.66 Gy), while for APBI the 
prescription was 38.5Gy (10x3.85Gy). The OARs - heart, lungs, 
contralateral breast, body, skin (the first 5 mm of ipsilateral breast 
tissue) - were subject to clinical constraints. To include the magnetic 
field in the dose calculations, in-house developed treatment planning 
software was used, based on GPU-based MonteCarlo calculations, and 
Fast Inverse Dose Optimization. IMRT plans were made for magnetic 
field strengths of 0T, 0.35T, and 1.5T. All plans were generated using 
a template of cost functions. Optimization was fluence-based only. 
Results 
Dose 
parameters  
Mean (SD) 
 
PTV  
D95 
(%) 
PTV 
D107 
(%) 
Ips.  
Mean 
lung 
dose 
(Gy) 
Heart 
V10Gy 
(%) 
Skin  
Mean 
dose 
(Gy) 
Skin  
V35Gy 
(%) 
WBI 0T 94.6 (0.5) 0 5.5 (2.0) 
1.7 
(2.2) 
29.9 
(1.9) 
50.6 
(6.0) 
 
0.35T 96.6 
(0.7) 0 5.6 (2.0) 
2.2 
(2.7) 
32.7 
(2.1) 
68.2 
(6.0) 
 
1.5T 96.5 
(0.7) 0 5.7 (2.0) 
2.2 
(2.7) 
34.5 
(2.2) 
73.9 
(5.2) 
APBI  0T 96.8 (0.8) 0 3.9 (1.7) 
0.7 
(1.6) 
5.2 
(2.0) 
2.5 
(2.7) 
 
0.35T 96.8 
(1.0) 0 3.6 (1.6) 
0.1 
(0.1) 
5.6 
(2.4) 
2.7 
(2.3) 
 
1.5T 96.8 
(0.7) 0 1.4 (1.4) 
0.3 
(0.8) 
5.8 
(2.4) 
3.0 
(2.3) 
For all plans the clinical dose constraints could be met using a 
template of cost functions (table 1). The skin dose was increased at 
non-zero field strengths for WBI (figure 1), while equal PTV coverage 
was achieved, with a small compromise on lung and heart dose. The 
average V35Gy for the skin was 50.6%, 68.2% and 73.9% for WBI at 0T, 
0.35T and 1.5T, respectively. For APBI, only minor effects were 
observed in the skin area: V35Gy was respectively 2.5%, 2.7% and 
3.0%.  
  
Conclusions: With the use of our planning system, acceptable IMRT 
plans for WBI and APBI in an MRL were generated employing a class 
solution. For WBI, the presence of a magnetic field resulted in an 
increased skin dose, which is a drawback if WBI treatments are to be 
performed on the MRL. For APBI however, the induced effects on the 
skin dose due to the magnetic field were small. This opens the 
possibilities for developing MR-guided treatments for APBI in the MRL. 
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Purpose/Objective: The aim of this study is to compare the dose 
distributions of intensity-modulated radiation therapy (IMRT) plans for 
patients with prostate cancer between MHI TM-2000 (VERO), 
TomoTherapy HiArt System (TomoTherapy), and conventional linac 
(Clinac 21EX), all of which are installed in our institution. 
Materials and Methods: Ten patients with localized prostate cancer 
treated by IMRT at our institution were included in this planning 
study. The clinical target volume (CTV) was defined as the prostate 
with or without the proximal seminal vesicles according to risk groups. 
The planning target volume (PTV) was defined as the CTV + three-
dimentional margins of 8 mm (5 mm on the rectal side). The rectum 
from the sigmoid flexure to the anal verge and the bladder were also 
delineated as solid organs. For each patient, IMRT planning was 
implemented for 3 different treatment machines, including VERO, 
TomoTherapy, and Clinac 21EX, so as to achieve the similar optimal 
dose delivery to the target volumes with the same dose constraints for 
normal tissues. IMRT schedule consisted of 76Gy in 38fr. As the 
method of IMRT, segmental multi-leaf collimator (MLC) IMRT with 7 
static ports, helical IMRT, and dynamic MLC IMRT with 7 static ports, 
were adopted for VERO, TomoTherapy, and Clinic 21EX, respectively. 
As planning software, iPlan ver.4.5.1, TomoTherapy Planning Station 
4.1.2, and Eclipse ver.10.0 were used for VERO, TomoTherapy, and 
Clinac 21EX, respectively.  
The dose-volume parameters described below were calculated in each 
treatment machine: D50 and D95 of the PTV and CTV; V40, V50, V60, 
V70 and V75 of the rectum; V65, V70 and V75 of the bladder. The 
mean values and standard deviations (SD) of each parameter among 
10 patients were calculated in each treatment machine, and 
compared between 3 treatment plans. 
Results: The dose-volume parameters calculated in each treatment 
machine are shown in the following Table. 
